An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India

BACKGROUND: Better drug regimens for mass drug administration (MDA) could accelerate the Global Programme to Eliminate Lymphatic Filariasis (LF). This community study was designed to compare the safety and efficacy of MDA with IDA (ivermectin, diethylcarbamazine and albendazole) or DA (diethylcarbam...

Descripción completa

Detalles Bibliográficos
Autores principales: Jambulingam, Purushothaman, Kuttiatt, Vijesh Sreedhar, Krishnamoorthy, Kaliannagounder, Subramanian, Swaminathan, Srividya, Adinarayanan, Raju, Hari Kishan K., Rahi, Manju, Somani, Roopali K., Suryaprakash, Mallanna K., Dwivedi, Gangeshwar P., Weil, Gary J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909694/
https://www.ncbi.nlm.nih.gov/pubmed/33591979
http://dx.doi.org/10.1371/journal.pntd.0009069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909694/
https://www.ncbi.nlm.nih.gov/pubmed/33591979
http://dx.doi.org/10.1371/journal.pntd.0009069

Ejemplares similares